08:50 - 09:00 |
Àλ縻 |
±è³²Áß (´ëÇÑ°¨¿°ÇÐȸ ÀÌ»çÀå) |
Session ¥° |
Antimicrobial Agents |
09:00 - 09:30 |
±Û¸®ÄÚÆéŸÀÌµå °è¿, ¸®³×Á¹¸®µå, Å×Æ®¶ó»çÀÌŬ¸° °è¿, ¸¶Å©·Ñ¶óÀÌµå °è¿ |
¹èÁöÀ± (ÀÌ´ë ¸ñµ¿º´¿ø) |
09:30 - 10:00 |
Ç×¹ÙÀÌ·¯½ºÁ¦ (HIV Á¦¿Ü) |
ÁÖÀºÁ¤ (°ºÏ »ï¼ºº´¿ø) |
10:00 - 10:15 |
ÈÞ½Ä |
Session ¥± |
Common clinical syndrome |
10:15 - 10:55 |
¿ä·Î°¨¿°ÀÇ Áø´Ü°ú Ä¡·á |
±èºÀ¿µ (ÇѾç´ëÇб³º´¿ø) |
10:55 - 11:35 |
ÆÐÇ÷ÁõÀÇ Áø´Ü°ú Ä¡·á |
±¸³²¼ö (¼¼ºê¶õ½º º´¿ø) |
11:35 - 12:15 |
C. difficile infection ÀÇ Áø´Ü°ú Ä¡·á |
±è¼ºÀº (Àü³²´ëÇб³º´¿ø) |
12:15 - 13:15 |
Á¡½É ½Ä»ç |
Session ¥² |
Special Host and Infection |
13:15 - 13:55 |
Áø±Õ ºÎºñµ¿¿° ȯÀÚÀÇ ÀÓ»ó¾ç»ó°ú Áø´Ü |
±è¹ÎÀç (¼¿ï ¾Æ»êº´¿ø) |
13:55 - 14:35 |
ÁßȯÀڽǰ¨¿°_Áß½ÉÁ¤¸Æ°ü °ü·Ã °¨¿° |
¹Ú±âÈ£ (°æÈñ´ëÇб³º´¿ø) |
14:35 - 15:15 |
¸é¿ªÀúÇÏÀÚ¿¡¼: CMV ¿¹¹æ ¹× Ä¡·á ¹æ¹ý |
Á¶¼º¿¬ (¼¿ï ¼º¸ðº´¿ø) |
15:15 - 15:30 |
ÈÞ½Ä |
Session ¥³ |
Special issues |
15:30 - 16:00 |
COVID-19 Ä¡·áÁ¦ °ü·Ã ÇöȲ |
ÃÖÆò±Õ (¼¿ï´ëÇб³ º´¿ø) |
16:00 - 16:30 |
¼ºÀÎ ¿¹¹æÁ¢Á¾¿¡ ´ëÇØ ¹Ù·Î ¾Ë±â |
³ëÁöÀ± (°í·Á´ëÇб³ ±¸·Îº´¿ø) |
16:30 - 16:40 |
ÄûÁîÇ®ÀÌ |